EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease

Shahzad S Khan iD, Ebsy Jaimon iD, Yu-En Lin iD, Jonas Nikoloff iD, Francesca Tonelli iD, Dario R Alessi iD, Suzanne R Pfeffer iD

Proceedings of the National Academy of Sciences · 06.08.2024 · 121 (32)

DOI: 10.1073/pnas.2402206121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024-08. Verfasst von Shahzad S Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Cilia, Parkinson Disease, Dopaminergic Neurons. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Aligning Science Across Parkinson's (ASAP), UKRI | Medical Research Council (MRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activating leucine-rich repeat kinase 2 (LRRK2) mutations cause Parkinson’s and phosphorylation of Rab10 by pathogenic LRRK2 blocks primary ciliogenesis in cultured cells. In the mouse brain, LRRK2 blockade of primary cilia is highly cell type specific: For example, cholinergic interneurons and astrocytes but not medium spiny neurons of the dorsal striatum lose primary cilia in LRRK2-pathway mutant mice. We show here that the cell type specificity of LRRK2-mediated cilia loss is also seen in human postmortem striatum from patients with LRRK2 pathway mutations and idiopathic Parkinson’s. Single nucleus RNA sequencing shows that cilia loss in mouse cholinergic interneurons is accompanied by decreased glial-derived neurotrophic factor transcription, decreasing neuroprotection for dopamine neurons. Nevertheless, LRRK2 expression differences cannot explain the unique vulnerability of cholinergic neurons to LRRK2 kinase as much higher LRRK2 expression is seen in medium spiny neurons that have normal cilia. In parallel with decreased striatal dopaminergic neurite density, LRRK2 G2019S neurons show increased autism-linked CNTN5 adhesion protein expression; glial cells show significant loss of ferritin heavy chain. These data strongly suggest that loss of cilia in specific striatal cell types decreases neuroprotection for dopamine neurons in mice and human Parkinson’s.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2CiliaParkinson DiseaseDopaminergic NeuronsNeuroprotectionAnimalsHumansMiceMutationCorpus StriatumMale

Stichwörter der Autor:innen

Hedgehog signalingLRRK2 kinaseParkinson’s diseaseRab GTPaseprimary cilia

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanLrrk2 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307.
  • Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD 20815.
  • Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee DD1 5EH, Scotland, United Kingdom.

ORCID-Profile: Shahzad S Khan, Ebsy Jaimon, Yu-En Lin, Jonas Nikoloff, Francesca Tonelli, Dario R Alessi, Suzanne R Pfeffer

Förderung

  • NIA NIH HHS
  • Aligning Science Across Parkinson's (ASAP)
  • UKRI | Medical Research Council (MRC)
  • NINDS NIH HHS
  • Michael J. Fox Foundation for Parkinson's Research (MJFF)

Zitieren

APA

Khan, S. S., Jaimon, E., Lin, Y. E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R. (2024). Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease. Proceedings of the National Academy of Sciences, 121(32). https://doi.org/10.1073/pnas.2402206121

Vancouver

Khan SS, Jaimon E, Lin YE, Nikoloff J, Tonelli F, Alessi DR, et al. Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease. Proceedings of the National Academy of Sciences. 2024;121(32). doi:10.1073/pnas.2402206121

BibTeX
@article{Khan2024,
  author = {Khan, Shahzad S and Jaimon, Ebsy and Lin, Yu-En and Nikoloff, Jonas and Tonelli, Francesca and Alessi, Dario R and Pfeffer, Suzanne R},
  title = {Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {32},
  doi = {10.1073/pnas.2402206121}
}
Kostenlos starten →